Table 2 Evolution of the cohort during the study period

Norepinephrine, n (%)

21 (27%)

14 (17%)

0*

Dobutamine, n (%)

14 (17%)

3 (4%)*

0*

Diuresis, median (IQR)

6 h (ml)

238 (170–348)

650 (329–948)*

470 (342–650)

6 h ml kg⁻¹ h⁻¹

0.5 (0.4–0.8)

1.4 (0.6–2.1)*

1 (0.8–1.5)

24 h fluid balance (ml), median (IQR)

989 (171–1589)

− 660 (− 1451–263)

− 1110 (− 2384 to − 16)*

Congestion criteria, n (%)

Pulmonary rales/crackles

31 (39%)

10 (12%)

4 (5%)

Peripheral edema

43 (53%)

30 (37%)

11 (14%)

B-lines, lung comets

18 (22%)

11 (14%)

5 (6%)

Pleural effusion

20 (25%)

19 (23%)

14 (17%)

Congestion score, median (IQR)

3 (2–4)

2 (1–3)

1 (0–2)*

NT-proBNP, (pg ml⁻¹), median (IQR)

2905 (929–5818)

2693 (1191–5194)

2175 (845–5854)*

Weight (Kg), mean (SD)

76 (17)

NA

75 (15)